Considerations when prescribing trimethoprim-sulfamethoxazole

CMAJ. 2011 Nov 8;183(16):1851-8. doi: 10.1503/cmaj.111152. Epub 2011 Oct 11.
No abstract available

Publication types

  • Review

MeSH terms

  • Abnormalities, Drug-Induced
  • Anti-Infective Agents / adverse effects*
  • Anticoagulants / adverse effects
  • Biomedical Research
  • Cytochrome P-450 Enzyme System / drug effects
  • Drug Eruptions
  • Drug Interactions
  • Female
  • Folic Acid Deficiency / chemically induced
  • Hematologic Diseases / chemically induced
  • Hemolysis / drug effects
  • Humans
  • Hyperkalemia / chemically induced
  • Hypoglycemia / chemically induced
  • Hypoglycemic Agents / adverse effects
  • Immunocompromised Host
  • Infant, Newborn
  • Infant, Small for Gestational Age
  • Kidney / drug effects
  • Nervous System Diseases / chemically induced
  • Pregnancy
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects*
  • Warfarin / adverse effects

Substances

  • Anti-Infective Agents
  • Anticoagulants
  • Hypoglycemic Agents
  • Warfarin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Cytochrome P-450 Enzyme System